Filed: 5/12/2025ACC: 0001104659-25-047243
📋 What this filing means
KNOTT DAVID M JR filed this quarterly 13F‑HR report disclosing 84 equity positions with a total reported market value of $211.95M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
84
Positions
$211.95M
Total AUM (reported)
14.72M
Total Shares
Allocation by class
COMMON$211.95M100.0%
Portfolio Concentration
Top 3$100.60M47.5%
4–10$54.06M25.5%
11–25$34.80M16.4%
Rest$22.50M10.6%
Top 3 weight
47.5%
Top 10 weight
73.0%
Voting Authority Distribution
Total shares with voting rights: 14.72M
Sole
Full voting authority
14.72M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole0
Shared0
Other84
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings84
Rows:
Calumet, Inc.
DFNDShares3.30M
TypeSH
Market value$41.81M
19.73%
Sole
3.30M
Shared
0.00
None
0.00
Apollo Global Management, Inc.
DFNDShares225K
TypeSH
Market value$30.81M
14.54%
Sole
225K
Shared
0.00
None
0.00
Janus Henderson AAA CLO ETF
DFNDShares551.76K
TypeSH
Market value$27.98M
13.20%
Sole
551.76K
Shared
0.00
None
0.00
Alphabet Inc-Cl C
DFNDShares112.22K
TypeSH
Market value$17.53M
8.27%
Sole
112.22K
Shared
0.00
None
0.00
DocGo, Inc.
DFNDShares3.07M
TypeSH
Market value$8.11M
3.82%
Sole
3.07M
Shared
0.00
None
0.00
Pfizer Inc.
DFNDShares254.54K
TypeSH
Market value$6.45M
3.04%
Sole
254.54K
Shared
0.00
None
0.00
Xeris Biopharma Holdings, Inc.
DFNDShares1.11M
TypeSH
Market value$6.09M
2.88%
Sole
1.11M
Shared
0.00
None
0.00
Verona Pharma PLC.
DFNDShares88K
TypeSH
Market value$5.59M
2.64%
Sole
88K
Shared
0.00
None
0.00
JPMorgan Chase & Co.
DFNDShares20.98K
TypeSH
Market value$5.15M
2.43%
Sole
20.98K
Shared
0.00
None
0.00
Catalyst Pharmaceuticals, Inc.
DFNDShares212K
TypeSH
Market value$5.14M
2.43%
Sole
212K
Shared
0.00
None
0.00
Travere Therapeutics, Inc.
DFNDShares228K
TypeSH
Market value$4.09M
1.93%
Sole
228K
Shared
0.00
None
0.00
Protagonist Therapeutics, Inc
DFNDShares76K
TypeSH
Market value$3.68M
1.73%
Sole
76K
Shared
0.00
None
0.00
BioCryst Pharmaceuticals, Inc.
DFNDShares460K
TypeSH
Market value$3.45M
1.63%
Sole
460K
Shared
0.00
None
0.00
Avadel Pharmaceuticals plc
DFNDShares426K
TypeSH
Market value$3.34M
1.57%
Sole
426K
Shared
0.00
None
0.00
Enstar Group Limited
DFNDShares7.50K
TypeSH
Market value$2.49M
1.18%
Sole
7.50K
Shared
0.00
None
0.00
Ardelyx, Inc.
DFNDShares493.81K
TypeSH
Market value$2.42M
1.14%
Sole
493.81K
Shared
0.00
None
0.00
OmniAB, Inc.
DFNDShares982.34K
TypeSH
Market value$2.36M
1.11%
Sole
982.34K
Shared
0.00
None
0.00
CSX Corporation
DFNDShares70K
TypeSH
Market value$2.06M
0.97%
Sole
70K
Shared
0.00
None
0.00
AllianceBernstein Holding L.P.
DFNDShares48K
TypeSH
Market value$1.84M
0.87%
Sole
48K
Shared
0.00
None
0.00
The Invesco AAA Floating Rate Note ETF
DFNDShares70.50K
TypeSH
Market value$1.80M
0.85%
Sole
70.50K
Shared
0.00
None
0.00
Ultragenyx Pharmaceutical Inc.
DFNDShares48K
TypeSH
Market value$1.74M
0.82%
Sole
48K
Shared
0.00
None
0.00
Syndax Pharmaceutical, Inc.
DFNDShares128K
TypeSH
Market value$1.57M
0.74%
Sole
128K
Shared
0.00
None
0.00
Myriad Genetics, Inc.
DFNDShares160K
TypeSH
Market value$1.42M
0.67%
Sole
160K
Shared
0.00
None
0.00
Cogent Biosciences Inc.
DFNDShares213.30K
TypeSH
Market value$1.28M
0.60%
Sole
213.30K
Shared
0.00
None
0.00
The Panagram BBB-B CLO ETF
DFNDShares47.81K
TypeSH
Market value$1.27M
0.60%
Sole
47.81K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Calumet, Inc.DFND | Common | 3.30M | SH | $41.81M 19.73% | 3.30M | 0.00 | 0.00 |
Apollo Global Management, Inc.DFND | Common | 225K | SH | $30.81M 14.54% | 225K | 0.00 | 0.00 |
Janus Henderson AAA CLO ETFDFND | Common | 551.76K | SH | $27.98M 13.20% | 551.76K | 0.00 | 0.00 |
Alphabet Inc-Cl CDFND | Common | 112.22K | SH | $17.53M 8.27% | 112.22K | 0.00 | 0.00 |
DocGo, Inc.DFND | Common | 3.07M | SH | $8.11M 3.82% | 3.07M | 0.00 | 0.00 |
Pfizer Inc.DFND | Common | 254.54K | SH | $6.45M 3.04% | 254.54K | 0.00 | 0.00 |
Xeris Biopharma Holdings, Inc.DFND | Common | 1.11M | SH | $6.09M 2.88% | 1.11M | 0.00 | 0.00 |
Verona Pharma PLC.DFND | Common | 88K | SH | $5.59M 2.64% | 88K | 0.00 | 0.00 |
JPMorgan Chase & Co.DFND | Common | 20.98K | SH | $5.15M 2.43% | 20.98K | 0.00 | 0.00 |
Catalyst Pharmaceuticals, Inc.DFND | Common | 212K | SH | $5.14M 2.43% | 212K | 0.00 | 0.00 |
Travere Therapeutics, Inc.DFND | Common | 228K | SH | $4.09M 1.93% | 228K | 0.00 | 0.00 |
Protagonist Therapeutics, IncDFND | Common | 76K | SH | $3.68M 1.73% | 76K | 0.00 | 0.00 |
BioCryst Pharmaceuticals, Inc.DFND | Common | 460K | SH | $3.45M 1.63% | 460K | 0.00 | 0.00 |
Avadel Pharmaceuticals plcDFND | Common | 426K | SH | $3.34M 1.57% | 426K | 0.00 | 0.00 |
Enstar Group LimitedDFND | Common | 7.50K | SH | $2.49M 1.18% | 7.50K | 0.00 | 0.00 |
Ardelyx, Inc.DFND | Common | 493.81K | SH | $2.42M 1.14% | 493.81K | 0.00 | 0.00 |
OmniAB, Inc.DFND | Common | 982.34K | SH | $2.36M 1.11% | 982.34K | 0.00 | 0.00 |
CSX CorporationDFND | Common | 70K | SH | $2.06M 0.97% | 70K | 0.00 | 0.00 |
AllianceBernstein Holding L.P.DFND | Common | 48K | SH | $1.84M 0.87% | 48K | 0.00 | 0.00 |
The Invesco AAA Floating Rate Note ETFDFND | Common | 70.50K | SH | $1.80M 0.85% | 70.50K | 0.00 | 0.00 |
Ultragenyx Pharmaceutical Inc.DFND | Common | 48K | SH | $1.74M 0.82% | 48K | 0.00 | 0.00 |
Syndax Pharmaceutical, Inc.DFND | Common | 128K | SH | $1.57M 0.74% | 128K | 0.00 | 0.00 |
Myriad Genetics, Inc.DFND | Common | 160K | SH | $1.42M 0.67% | 160K | 0.00 | 0.00 |
Cogent Biosciences Inc.DFND | Common | 213.30K | SH | $1.28M 0.60% | 213.30K | 0.00 | 0.00 |
The Panagram BBB-B CLO ETFDFND | Common | 47.81K | SH | $1.27M 0.60% | 47.81K | 0.00 | 0.00 |
Page 1 of 4